Expressing support for equitable access to transformative therapies for sickle cell disease.
Bill status
signed
all 5 stages cleared
Introduction
May 2021
Committee Review
May 2021
House Passage
May 2021
Senate Passage
May 2021
Signed into Law
Jun 2021
Introduced May 19, 2021
Signed Jun 18, 2021
Floor votes
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
35
Key actions
8
Committee
8
Jun 18, 2021
Signed into law
Signed by the Governor
executive
May 24, 2021
Upper · Passed
Adopted
upper
May 22, 2021
Upper · Passed
Committee report printed and distributed
upper
May 21, 2021
Upper · Passed
Reported favorably w/o amendments
upper
May 19, 2021
Committee
Referred to Health & Human Services
upper
May 19, 2021
Introduced
Read first time
upper
May 19, 2021
Introduced
Received from the House
upper
May 18, 2021
Lower · Passed
Adopted
lower
May 11, 2021
Lower · Passed
Committee report distributed
lower
May 11, 2021
Lower · Passed
Comte report filed with Committee Coordinator
lower
May 10, 2021
Lower · Passed
Reported favorably w/o amendment(s)
lower
May 10, 2021
Committee
Recommended to be sent to Local & Consent
lower
Apr 19, 2021
Committee
Referred to Public Health
lower
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HCR 86
Scope: TX
Hi! I can help you understand HCR 86. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline